2L7K

Solution NMR Structure of protein CD1104.2 from Clostridium difficile, Northeast Structural Genomics Consortium Target CfR130

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
2	2D 1H-13C HSQC aliphatic	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
3	2D 1H-13C HSQC aromatic	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
4	(4,3)D GFT-HNCACBCA	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
5	(4,3)D GFT-CBCACA(CO)NHN	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
6	3D HNCO	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
7	3D HN(CA)CO	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
8	3D GFT HCCH-COSY-ali	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
9	3D GFT HCCH-COSY-aro	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
10	3D simutaneous 13C-aromatic,13C-aliphatic,15N edited 1H-1H NOESY	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
11	3D HCCH-TOCSY-ali	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
12	2D 1H-13C CT-HSQC aliphatic	1.68 mM [U-5% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
13	(4,3)D GFT-HABCAB(CO)NHN	1.61 mM [U-100% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS	95% H2O/5% D2O	0.11	6.5	1 atm	298
14	2D 1H-15N J-modulated HSQC	1.68 mM [U-5% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 4 % PEG	90% H2O/10% D2O	0.11	6.5	1 atm	298
15	2D 1H-15N J-modulated HSQC	1.68 mM [U-5% 13C; U-100% 15N] CfR130, 20 mM MES, 100 mM sodium chloride, 0.02 % sodium azide, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 13.2 mg/ml Pf1 phage	90% H2O/10% D2O	0.11	6.5	1 atm	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	500
2	Varian	INOVA	600
3	Varian	INOVA	750

NMR Refinement
Method	Details	Software
simulated annealing	energy minimization	CNS

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
2	structure solution	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
3	geometry optimization	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
4	structure solution	CYANA	3.0	Guntert, Mumenthaler and Wuthrich
5	data analysis	AutoStructure	2.1	Huang, Tejero, Powers and Montelione
6	refinement	AutoStructure	2.1	Huang, Tejero, Powers and Montelione
7	structure solution	AutoStructure	2.1	Huang, Tejero, Powers and Montelione
8	data analysis	AutoAssign	2.1	Zimmerman, Moseley, Kulikowski and Montelione
9	chemical shift assignment	AutoAssign	2.1	Zimmerman, Moseley, Kulikowski and Montelione
10	data analysis	XEASY		Bartels et al.
11	peak picking	XEASY		Bartels et al.
12	chemical shift assignment	XEASY		Bartels et al.
13	collection	VnmrJ		Varian
14	geometry optimization	TALOS+		Shen, Cornilescu, Delaglio and Bax
15	data analysis	CARA	1.8.4	Keller and Wuthrich
16	processing	PROSA	6.4	Guntert
17	analysis of structure	PSVS		Bhattacharya and Montelione

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.